A review of the latest epidemiological evidence strengthens a causal link between the consumption of alcohol and cancers at seven sites in the body.
Results from the ongoing VIVIANE study find the human papillomavirus 16/18 vaccine is effective in protecting women over the age of 25 years against infection.
Phase III data indicate that regorafenib increases survival rates in patients with hepatocellular carcinoma, highlighting potential as a second-line therapy.
Low-dose brachytherapy studies have demonstratedequivalent local and distant tumor control with reduced radiation complications – read more in this perspective article.
This review article from Future Oncology explores the roles of miRNAs in pancreatic cancer development and the potential of miRNA-based therapeutics.
Risk factors, biomarkers and potential preventative strategies are dicussed in this review article on chemotherapy-induced cardiotoxicity in breast cancer patients.